SBIR/STTR Research Award

"TWO-WAVELENGTH LASER FOR SURGERY"

Award identifier c3216f976d547e7f83e59d58e6cc66f3adc22ae70eaeab62107161fca0c2003dAwarding agency Department of Health and Human Services

Award amount

$456,000

Program and phase

SBIR · Phase II

Award year

1986

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
ABIOMED, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
KBGSE7HJSDE3
Solicitation number
Not reported
Topic code
Not reported

Research abstract

THE USE OF LASERS AS A SURGICAL MODALITY HAS BEEN ESTABLISHED IN RECENT YEARS. LASERS OF VARIOUS WAVELENGTHS ARE SUITED FOR DIFFERENT SPECIFIC SURGICAL FUNCTIONS. CO2 (10.6 ) RADIATION HAS SMALL PENETRATION DEPTHS IN TISSUES. THIS LEADS TO HIGH SURFACE TEMPERATURES WHICH ARE DESIRABLE FOR TISSUE INCISION THROUGH EVAPORATION. ND:YAG LASERS (1.06 ) PROVIDE VOLUMETRIC TISSUE HEATING WHICH IS EFFECTIVE IN VASCULAR COAGULATION. IN THE TREATMENT OF TUMORS AND CANCEROUS TISSUES, CONCURRENT HEMOSTASIS AND INCISION ARE NECESSARY REQUIREMENTS FOR WIDESPREAD CLINICAL APPLICATIONS OF LASERS AS SURGICAL TOOLS. THE SPECIFIC AIM OF THIS PROPOSED EFFORT IS DIRECTED TOWARDS THE DEVELOPMENT OF A NEW SURGICAL LASER SYSTEM CAPABLE OF PROVIDING THESE SIMULTANEOUS FUNCTIONS. THE SYSTEM HAS THE ADVANTAGES OF A SINGLE POWER SUPPLY AND ONE LASER HEAD. IT CAN PROVIDE THE ADDED FUNCTION OF CUTTING, WHICH ND-YAG ALONE CANNOT SUITABLY PERFORM. IT SHOULD ACCOMPLISH HEMOSTASIS OF VASCULAR REGIONS WHERE CO2 IS NOT ADEQUATE. IN ADDITION, AN IMPORTANT FEATURE IS ITS COMPATIBILITY WITH CONVENTIONAL QUARTZ FIBER OPTICS DELIVERY SYSTEM. SUCH A LASER WILL HAVE WIDESPREAD CLINICAL APPLICATIONS AND COMMERCIAL POTENTIAL. THIS RESEARCH EFFORT NATURALLY FALLS WITHIN THE REALM OF PROGRAM ACTIVITIES SPONSORED BY THE DIVISION OF CANCER TREATMENT, NATIONAL CANCER INSTITUTE. THE OBJECTIVES OF THIS PHASE I PROGRAM ARE TWO FOLD. (1) A COMPLETE DESIGN AND ANALYSIS OF THE LASER SYSTEM CAPABLE OF DELIVERING THE NECESSARY POWERS AT 1.06 AND 1.9 WILL BE PERFORMED. (2) EXPERIMENTS WILL BE CONDUCTED TO DETERMINE TISSUE ABSORPTION AND INTERACTION CHARACTERISTICS AT 1.9 , THUS VERIFYING THE POWER LEVELS NECESSARY FOR INCISION. RESULTS FROM PHASE I WILL PROVIDE THE BASIS FOR A PHASE II PROGRAM TO FABRICATE THIS LASER AND CONDUCT IN VIVO ANIMAL EXPERIMENTS.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

63 SBIR/STTR records share this UEI (1983–2011). Reported award amounts total $17,365,096. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.